A US appeals court has lifted its stay on a sales ban on two editions of the Apple Watch, creating another hurdle in the tech giant’s legal dispute with health technology company Masimo over patents for its blood oxygen tracking function.
The International Trade Commission ruled in October that Apple was violating Masimo’s patents with the latest versions of its Watch, prompting the company to pull the devices from its online and physical stores in the US ahead of Christmas.
After the brief pause, Apple resumed US sales when the US court of appeals for the federal circuit granted its request for a stay on enforcement of the ban.
On Wednesday, the same court opted to lift that stay, refusing Apple’s request to extend it until its appeal of the ITC ruling concludes.